Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition used for treating herpes zoster

A technology of herpes zoster and composition, which is applied in the field of composition for treating herpes zoster, can solve the problem that herpes zoster cannot be cured, and achieve the effect of preventing recurrence and having obvious effect

Inactive Publication Date: 2015-01-07
张秀荣
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is to provide a kind of medicine component that is used for treating herpes zoster, has solved the problem that herpes zoster that exists in the prior art cannot be cured radically

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] A composition for treating herpes zoster, consisting of the following components in parts by weight:

[0020] Vitamin B1: 100mg; Cleanmycin: 0.6g; Vitamin B12: 500wg; Ribavirin: 400mg; Dexamethasone: 2mg, prepared into injections according to the conventional process, and treated 30 patients with herpes zoster with the above drugs , 30 patients all had their herpes shrunk after four days of medication, and herpes peeled off completely after seven days without any sequelae. The patient was followed up and observed, and it was found that the patient had no recurrence within 5 years.

Embodiment 2

[0022] A composition for treating herpes zoster, consisting of the following components in parts by weight: vitamin B1: 50mg, lincomycin: 0.8g, vitamin B12: 200μg, ribavirin: 500mg, dexamethasone: 2mg . According to the routine process, it was prepared into an injection, and 30 patients with herpes zoster were treated with the above-mentioned medicine. The herpes shrank after four days of medication in all 30 patients, and the herpes peeled off completely after seven days without any sequelae. The patient was followed up and observed, and it was found that the patient had no recurrence within 5 years.

Embodiment 3

[0024] A composition for treating herpes zoster, which consists of the following components in parts by weight: vitamin B1: 100 mg, cleomycin 0.6 g, vitamin B12: 500 μg, ribavirin 200 mg, and dexamethasone: 20 mg. According to the routine process, it was prepared into an injection, and 30 patients with herpes zoster were treated with the above-mentioned medicine. The herpes shrank after four days of medication in all 30 patients, and the herpes peeled off completely after seven days without any sequelae. The patient was followed up and observed, and it was found that the patient had no recurrence within 5 years.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses composition used for treating herpes zoster. The composition used for treating the herpes zoster comprises, by mass, 50 mg-100 mg of vitamin B1, 0.6 g-0.8 g of lincomycin, 200 microgram-500 microgram of vitamin B12, 200 mg-500 mg of ribavirin and 2 mg-20 mg of dexamethasone. The composition can be used for fundamentally curing the herpes zoster, and can prevent the herpes zoster from recurring.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a composition for treating herpes zoster. Background technique [0002] Herpes zoster is an acute infectious skin disease caused by the varicella zoster virus. Chickenpox occurs in children and the elderly who are not immune to the virus. After being infected, some patients become carriers without symptoms. Due to the neurotropic nature of the virus, it can remain dormant in the neurons of the dorsal root ganglia of the spinal cord for a long time after infection. When the resistance is low or when you are tired, infected, or caught a cold, the virus can grow and multiply again, and move to the skin along the nerve fibers. Intense inflammation of affected nerves and skin. The rash is generally unilateral and distributed according to nerve segments, and consists of clustered herpes, accompanied by severe pain and unbearable pain; the older you are, the more severe ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/714A61K9/08A61P31/22A61K31/51A61K31/7056A61K31/573
CPCA61K31/714A61K9/0014A61K9/0019A61K9/0053A61K9/06A61K9/08A61K9/12A61K31/51A61K31/573A61K31/7056
Inventor 张秀荣
Owner 张秀荣
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com